1. Marzi S,
Stefanetti L,
Sperati F,
et al (2016) Relationship between diffusion parameters derived from intravoxel incoherent motion MRI and perfusion measured by dynamic contrast-enhanced MRI of soft tissue tumors.
NMR Biomed 29:6.
2. Noebauer-Huhmann IM,
Amann G,
Krssak M,
et al (2015) Use of diagnostic dynamic contrast-enhanced (DCE)-MRI for targeting of soft tissue tumour biopsies at 3T: preliminary results.
Eur Radiol 25:2041-2048.
3. Nakamura T,
Matsumine A,
Matsubara T,
et al (2011) The symptom-to-diagnosis delay in soft tissue sarcoma influence the overall survival and the development of distant metastasis.
J Surg Oncol 104:771-775.
4. Khalifa F,
Soliman A,
El-Baz A,
et al (2014) Models and methods for analyzing DCE-MRI: A review.
Med Phys 41:1-32.
5. Park MY,
Jee WH,
Sun KK,
et al (2013) Preliminary Experience Using Dynamic MRI at 3.0 Tesla for Evaluation of Soft Tissue Tumors.
Korean J Radiol 14:102-109.
6. Verstraete KL,
Lang P (2000) Bone and soft tissue tumors: the role of contrast agents for MR imaging.
Eur J Radiol 34:229-246.
7. Tuncbilek N,
Karakas HM,
Okten OO (2005) Dynamic contrast enhanced MRI in the differential diagnosis of soft tissue tumors.
Eur J Radiol 53:500-505.
8. Yang Q,
Li LH,
Zhang J,
et al (2015) A new quantitative image analysis method for improving breast cancer diagnosis using DCE-MRI examinations.
Med Phys 42:103-109.
9. Li L,
Wang K,
Sun XL,
et al (2015) Parameters of Dynamic Contrast-Enhanced MRI as Imaging Markers for Angiogenesis and Proliferation in Human Breast Cancer.
Med Sci Monitor 21:376-382.
10. Bergamino M,
Bonzano L,
Levrero F,
et al (2014) A review of technical aspects of T1-weighted dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) in human brain tumors.
Phys Med 30:635-643.
11. Zhang N,
Zhang L,
Qiu B,
et al (2012) Correlation of volume transfer coefficient Ktrans with histopathologic grades of gliomas.
J Magn Reson Imaging 36:355-363.
12. Alonzi R,
Padhani AR,
Allen C (2007) Dynamic contrast enhanced MRI in prostate cancer.
Eur J Radiol 63:335-350.
13. Lowry M,
Zelhof B,
Liney GP,
et al (2009) Analysis of prostate DCE-MRI: comparison of fast exchange limit and fast exchange regimen pharmacokinetic models in the discrimination of malignant from normal tissue.
Invest Radiol 44:577-584.
14. Kim JI,
Lee IS,
Song YS,
et al (2016) Short-term follow-up MRI after unplanned resection of malignant soft-tissue tumours quantitative measurements on dynamic contrast enhanced and diffusion-weighted MR images.
Br J Radiol 89:20160302.
15. Nystrom LM,
Reimer NB,
Dean CW,
et al (2015) Evaluation of imaging utilization prior to referral of musculoskeletal tumors: a prospective study.
J Bone Joint Surg Am 97:10-15.
16. Hansford BG,
Stacy GS (2015) From tumor to trauma: etiologically deconstructing a unique differential diagnosis of musculoskeletal entities with high signal intensity on T1-weighted MRI.
AJR 204:817-826.
17. Sourbron SP,
Buckley DL (2013) Classic models for dynamic contrast-enhanced MRI.
NMR Biomed 26:1004-1027.
18. Schacht DV,
Drukker K,
Pak I,
et al (2015) Using quantitative image analysis to classify axillary lymph nodes on breast MRI: A new application for the Z 0011 Era.
Eur J Radiol 84:392-397.
19. Harry VN,
Semple SI,
Parkin DE,
et al (2010) Use of new imaging techniques to predict tumour response to therapy.
Lancet Oncol 11:92-102.
20. O'Connor JPB,
Jackson A,
Parker GJM,
et al (2012) Dynamic contrast-enhanced MRI in clinical trials of antivascular therapies.
Nat Rev Clin Oncol 9:167-177.
21. Hylton N (2006) Dynamic contrast-enhanced magnetic resonance imaging as an imaging biomarker.
J Clin Oncol 24:3293.
22. Miller JC,
Pien HH,
Sahani D,
et al (2005) Imaging angiogenesis: applications and potential for drug development.
J Natl Cancer Inst 97:172-187.
23. Turkbey B,
Thomasson D,
Pang Y,
et al (2010) The role of dynamic contrast-enhanced MRI in cancer diagnosis and treatment.
Diagn Interv Radiol 16:186-192.
24. Geirnaerdt MJA,
Hogendoorn PCW,
Bloem JL,
et al (2000) Cartilaginous Tumors: Fast Contrast-enhanced MR Imaging.
Radiology 214:539-546.
25. O'Connor JP,
Jackson A,
Parker GJ,
et al (2007) DCE-MRI biomarkers in the clinical evaluation of antiangiogenic and vascular disrupting agents.
Br J Cancer 96:189-195.
26. Agner SC,
Rosen MA,
Englander S,
et al (2014) Computerized Image Analysis for Identifying Triple-Negative Breast Cancers and Differentiating Them from Other Molecular Subtypes of Breast Cancer on Dynamic Contrast-enhanced MR Images: A Feasibility Study.
Radiology 272:91-99.
27. Sourbron S (2010) Technical aspects of MR perfusion.
Eur J Radiol 76:304-313.
28.
Yankeelov TE,
Gore JC (2007) Dynamic Contrast Enhanced Magnetic Resonance Imaging in Oncology: Theory,
Data Acquisition,
Analysis,
and Examples.
Curr Med Imaging Rev 3:91-107.
29. Paldino MJ,
Barboriak DP (2009) Fundamentals of quantitative dynamic contrast-enhanced MR imaging.
Magn Reson Imaging Clin N Am 17:277-289.
30. Rodjan F,
De Graaf P,
Van der Valk P,
et al (2012) Retinoblastoma: value of dynamic contrast-enhanced MR imaging and correlation with tumor angiogenesis.
Am J Neuroradiol 33:2129-2135.